Opioid-related neurocognitive symptoms among patients on long-term opioid therapy were most prevalent during the course of therapy.

Candidate genetic variants included in a genetic risk algorithm may not meet standards of reasonable clinical efficacy in identifying opioid use disorder risk, according to a study published in JAMA ...

Beltrami County's Opioid Steering Committee has once again opened up applications for grant funding and invited community organizations and partners to apply. An estimated $70,000 is available for the ...

Reversing opioid overdoses in rats using a drug that does not enter the brain prevents the sudden and severe withdrawal symptoms associated with therapeutics that target the central nervous system.

A new congressionally mandated report examines how opioid and benzodiazepine prescribing between 2007 and 2019 impacted all-cause mortality among veterans treated at the VHA.

A new study led by researchers at University Hospitals Connor Whole Health found that adults with newly diagnosed sciatica ...

A new study led by researchers at University Hospitals Connor Whole Health found that adults with newly diagnosed sciatica ...

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

Patients with opioid use disorder enrolled in Medicaid were less likely to receive telehealth care after the COVID-19 ...

The Delaware Prescription Opioid Settlement Commission has a new co-chair.

Acadia Healthcare Co. Inc. will again face a whistleblower’s False Claims Act suit alleging that the company improperly billed federal health-care programs for treatment related to opioid use disorder ...